326 related articles for article (PubMed ID: 34811715)
1. Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
Agin-Liebes G; Davis AK
Curr Top Behav Neurosci; 2022; 56():125-140. PubMed ID: 34811715
[TBL] [Abstract][Full Text] [Related]
2. Role of Psychedelics in Treatment-Resistant Depression.
Kamal S; Jha MK; Radhakrishnan R
Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
[TBL] [Abstract][Full Text] [Related]
3. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
Pearson C; Siegel J; Gold JA
J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
[TBL] [Abstract][Full Text] [Related]
4. Return of the psychedelics: Psilocybin for treatment resistant depression.
Patra S
Asian J Psychiatr; 2016 Dec; 24():51-52. PubMed ID: 27931907
[TBL] [Abstract][Full Text] [Related]
5. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Rosenblat JD; Husain MI; Lee Y; McIntyre RS; Mansur RB; Castle D; Offman H; Parikh SV; Frey BN; Schaffer A; Greenway KT; Garel N; Beaulieu S; Kennedy SH; Lam RW; Milev R; Ravindran AV; Tourjman V; Ameringen MV; Yatham LN; Taylor V
Can J Psychiatry; 2023 Jan; 68(1):5-21. PubMed ID: 35975555
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.
Gill H; Puramat P; Patel P; Gill B; Marks CA; Rodrigues NB; Castle D; Cha DS; Mansur RB; Rosenblat JD; McIntyre RS
Psychiatry Res; 2022 Jul; 313():114577. PubMed ID: 35580433
[TBL] [Abstract][Full Text] [Related]
7. Next generation antidepressants with novel mechanisms for treatment resistant depression.
Chen MH; Tu PC; Su TP
Prog Brain Res; 2023; 278():149-168. PubMed ID: 37414491
[TBL] [Abstract][Full Text] [Related]
8. Psychedelics for treatment resistant depression: are they game changers?
Kalfas M; Taylor RH; Tsapekos D; Young AH
Expert Opin Pharmacother; 2023; 24(18):2117-2132. PubMed ID: 37947195
[TBL] [Abstract][Full Text] [Related]
9. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
Wulff AB; Nichols CD; Thompson SM
Neuropharmacology; 2023 Jun; 231():109504. PubMed ID: 36921889
[TBL] [Abstract][Full Text] [Related]
10. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
Haikazian S; Chen-Li DCJ; Johnson DE; Fancy F; Levinta A; Husain MI; Mansur RB; McIntyre RS; Rosenblat JD
Psychiatry Res; 2023 Nov; 329():115531. PubMed ID: 37844352
[TBL] [Abstract][Full Text] [Related]
11. Psilocybin for Treatment-Resistant Depression.
Lengvenyte A; Olié E; Courtet P
N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812445
[No Abstract] [Full Text] [Related]
12. Psilocybin for Treatment-Resistant Depression.
Roméo B; Dervaux A; Benyamina A
N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812444
[No Abstract] [Full Text] [Related]
13. Psilocybin for Treatment-Resistant Depression.
Østergaard SD; Hieronymus F
N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812443
[No Abstract] [Full Text] [Related]
14. [Contribution of serotonin 5-HT
Ibi D
Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
[TBL] [Abstract][Full Text] [Related]
15. Psilocybin for Treatment-Resistant Depression. Reply.
Goodwin GM; Hellerstein DJ; Young AH
N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812446
[No Abstract] [Full Text] [Related]
16. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.
Skosnik PD; Sloshower J; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC
J Psychopharmacol; 2023 Jul; 37(7):687-697. PubMed ID: 37392016
[TBL] [Abstract][Full Text] [Related]
17. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.
Galvão-Coelho NL; Marx W; Gonzalez M; Sinclair J; de Manincor M; Perkins D; Sarris J
Psychopharmacology (Berl); 2021 Feb; 238(2):341-354. PubMed ID: 33427944
[TBL] [Abstract][Full Text] [Related]
18. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
[TBL] [Abstract][Full Text] [Related]
19. Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.
Sloshower J; Skosnik PD; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC
J Psychopharmacol; 2023 Jul; 37(7):698-706. PubMed ID: 36938991
[TBL] [Abstract][Full Text] [Related]
20. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.
Stroud JB; Freeman TP; Leech R; Hindocha C; Lawn W; Nutt DJ; Curran HV; Carhart-Harris RL
Psychopharmacology (Berl); 2018 Feb; 235(2):459-466. PubMed ID: 29085980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
